The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)
S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …
Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines
W Ageno, AS Gallus, A Wittkowsky, M Crowther… - Chest, 2012 - Elsevier
Background The objective of this article is to summarize the published literature concerning
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …
2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing …
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …
decision pathways, health policy statements, appropriate use criteria) to provide members …
[PDF][PDF] 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
M Sousa-Uva*, SJ Head, M Milojevic… - European Journal of …, 2018 - academic.oup.com
Disclaimer 2017: The EACTS Guidelines represent the views of the EACTS and were
produced after careful consideration of the scientific and medical knowledge and the …
produced after careful consideration of the scientific and medical knowledge and the …
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart …
WN Kernan, B Ovbiagele, HR Black, DM Bravata… - Stroke, 2014 - Am Heart Assoc
The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …
recommendations on the prevention of future stroke among survivors of ischemic stroke or …
[PDF][PDF] National clinical guideline for stroke
ISW Party - 2012 - askdoris.org
This is the fourth edition of the UK National clinical guideline for stroke. It is an integral part
of the broader goal of the Intercollegiate Stroke Working Party to improve the care of people …
of the broader goal of the Intercollegiate Stroke Working Party to improve the care of people …
Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based …
Background High-quality anticoagulation management is required to keep these narrow
therapeutic index medications as effective and safe as possible. This article focuses on the …
therapeutic index medications as effective and safe as possible. This article focuses on the …
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association …
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke …
Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical …
Background The risk of stroke varies considerably across different groups of patients with
atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased …
atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased …
Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
Background—The Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY)
trial showed that dabigatran etexilate 150 mg BID was superior and dabigatran etexilate 110 …
trial showed that dabigatran etexilate 150 mg BID was superior and dabigatran etexilate 110 …